BIOMAT Database Logo BIOMAT Database Logo

Synthesis of certain heterodimers expected as HIV-1 reverse transcriptase inhibitors. 2003

D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Centre d'Etudes et de Recherche sur le Médicament de Normandie U.F.R. des Sciences Pharmaceutiques, Caen, France.

Expected for the ability to inhibit HIV replication, we report the synthesis of two heterodimers of the general formula: [2NRTI]-C5-GLY-SUCCINYL-Npiperazinyl-[NNRTI] (18, 19) containing both a Nucleoside Reverse Transcriptase Inhibitor (10, 11) and a Non-Nucleoside Reverse Transcriptase Inhibitor (8) [Trovirdine Analogue belonging of the phenethyl thiazolyl thiourea class] connected through the "succinyl-glycine" spontaneously cleavable linker.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019281 Dimerization The process by which two molecules of the same chemical composition form a condensation product or polymer. Dimerizations

Related Publications

D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors.
August 2000, Bioorganic & medicinal chemistry letters,
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
HIV-1 reverse transcriptase inhibitors.
June 2007, Applied microbiology and biotechnology,
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors.
July 2001, Bioorganic & medicinal chemistry letters,
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Inhibitors of HIV-1 reverse transcriptase.
January 2008, Advances in pharmacology (San Diego, Calif.),
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Inhibitors of HIV-1 reverse transcriptase.
January 2000, Advances in pharmacology (San Diego, Calif.),
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 reverse transcriptase.
August 2013, Organic and medicinal chemistry letters,
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
August 1996, Journal of medicinal chemistry,
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors.
December 2004, Journal of enzyme inhibition and medicinal chemistry,
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Novel HIV-1 reverse transcriptase inhibitors.
June 2008, Virus research,
D Ladurée, and E Sugeac, and C Fossey, and S Schmidt, and G Laumond, and A M Aubertin
Specific HIV-1 reverse transcriptase inhibitors.
January 1992, Journal of enzyme inhibition,
Copied contents to your clipboard!